Cameron J.Gable

Associate

San Diego + 1.858.314.1128

Connect:

Share

Cameron Gable counsels and represents clients in international trade, national security, foreign investment, and environmental matters. He has represented clients in investment reviews conducted by the Committee on Foreign Investment in the United States (CFIUS) and assisted clients in navigating and understanding economic sanctions, including sanctions regimes administered by the Office of Foreign Assets Control (OFAC). He also has counseled companies in matters involving California's expansive environmental laws. More recently, Cameron has assisted clients with understanding and navigating the Creating Helpful Incentives to Produce Semiconductors Act (CHIPS Act).

Cameron's broad regulatory experience has involved counseling clients from a variety of industries, including energy, agriculture, life sciences, semiconductors, medical devices, and consumer goods.

Experience

  • Marubeni sells global grain business of Gavilon Agriculture InvestmentJones Day advised Marubeni Corporation in the sale of the global grain business of Gavilon Agriculture Investment, Inc. to Viterra Limited, following a reorganization of Gavilon’s structure.
  • Sensata Technologies acquires DynapowerJones Day advised Sensata Technologies (NYSE: ST), a leading industrial technology company and provider of sensor-rich solutions and insights for customers, in connection with its acquisition of Dynapower Company, LLC, a leading provider of energy storage and power conversion systems, from private equity firm Pfingsten Partners for $580 million in cash.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day is advising Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
    • View All

    November 2022 Newsletters

    California Enacts Sweeping Climate Measures

    September 2022 Alert

    Commerce Releases CHIPS Act Strategy

    March 2022 Newsletters

    Vital Signs: Digital Health Law Update | Winter 2022

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.